Morningstar‘s Stock Analysis NWCI
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile NWCI
Newcardio Inc. focuses on the research, development and commercialization of products and services for the non-invasive diagnosis and monitoring of cardiovascular disease, as well as the cardiac safety assessment of new drugs under development.
Somerset, NJ, 08853